MALAT1 is, among lncRNAs, a stable and highly transcribed molecule localized in the nucleus, and it has been reported that, in breast cancer cells expressing ERα, 17β-estradiol treatment negatively regulates MALAT1 transcription, thus inhibiting proliferation, migration and invasion (66). This evidence concerns the gene MALAT1 and breast carcinoma.